TrialAlzheimer's research & therapy2025

Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer's disease.

Gabriel L Ketron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.